Charles R. (Chas) Eggert brings 40 years of experience in the global specialty chemicals industry to the board of Huber Engineered Materials (HEM). Eggert is an Operating Partner at Arsenal Capital Partners, a New York City-based private equity firm that acquires and works with management teams to rapidly grow specialty chemical and health care services companies.
From 2008 to 2014, Eggert was President & CEO of OPX Biotechnologies, Inc., a venture capital financed company using biotechnology to produce chemicals from renewable raw materials. Eggert worked at the National Starch and Chemical Company of ICI PLC from 1999 to 2007 as Vice President of Personal Care and Vice President of Food Ingredients–Europe before being named Group Vice President of Specialty Polymers.
With the acquisition of ICI by Akzo Nobel in 2008, he was named President of the Specialty Polymers Group. Eggert served as Vice President of Sales and Marketing with Engelhard Corporation from 1997 to 1999. Eggert began his career with Monsanto Company, progressing over 20 years through roles with increasing responsibilities in technology, manufacturing, business development, marketing and general management.
In addition to the HEM Board, Eggert serves as a Board Director of Spartech LLC and Carolina Color LLC, both Arsenal Capital portfolio companies. He is a Governance Fellow of the National Association of Corporate Directors.
Previous board director positions include the American Chemistry Council and the Biotechnology Industry Organization. He was a Founding Director and Chairman of the Colorado Cleantech Industry Association.
Eggert holds a BS in chemical engineering and an MBA from Washington University in St. Louis, as well as an MS in biochemical engineering from the University of Minnesota.